Rachel L. Mintz

932 citations
30 papers · 632 indexed · h-index 14
Topics
CRISPR and Genetic Engineering (7 papers)RNA Interference and Gene Delivery (6 papers)Advanced biosensing and bioanalysis techniques (6 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Rachel L. Mintz

27 papers receiving 629 citations

Peers

Rachel L. Mintz
Comparison fields: 5 of 91
  • Molecular Biology 292
  • Biomedical Engineering 209
  • Biomaterials 117
  • Materials Chemistry 94
  • Oncology 89
Replace María Julia Martín with:
María Julia Martín Argentina
Yan Du China
Se‐Lim Kim South Korea
Chia‐Yi Lin Taiwan
Lina Guo China
Qiu Tu China
Sujan Kumar Mondal United States
Rachel L. Mintz relative to María Julia Martín Argentina María Julia Martín's profile →
Citations per field
00.5×3.4×
María Julia Martín · 1×
Citations per year

Countries citing papers authored by Rachel L. Mintz

Since Specialization
Citations

This map shows the geographic impact of Rachel L. Mintz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel L. Mintz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel L. Mintz more than expected).

Fields of papers citing papers by Rachel L. Mintz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel L. Mintz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel L. Mintz. The network helps show where Rachel L. Mintz may publish in the future.

Co-authorship network of co-authors of Rachel L. Mintz

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel L. Mintz. A scholar is included among the top collaborators of Rachel L. Mintz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel L. Mintz. Rachel L. Mintz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 31
5 2
6 16
7 31
8 4
9 29
10 3
11 40
12 4
13 5
14 6
15 42
16 4
17 78
18 72
19 11
20
Selected statistics for January 1981.
2

About Rachel L. Mintz

Rachel L. Mintz is a scholar working on Biomaterials, Cancer Research and Molecular Biology, having authored 30 papers that have together received 632 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (7 papers), RNA Interference and Gene Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Biomaterials (117 citations), Biomedical Engineering (209 citations) and Nephrology (33 citations). Rachel L. Mintz has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Mingqiang Li, Yeh‐Hsing Lao, Yu Tao, Kam W. Leong, Dan Shao, Ke Yi, Hanze Hu, Huimin Kong, Malvika Solanki and Christine N. Metz. Their work appears in journals such as Advanced Materials, Nature Communications and Nano Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026